Previous studies have found that simvastatin treatment reduces retinal cholesterol and increases the retinal expression of CD36, suggesting that statins may be involved in the treatment of lipid metabolism-related eye diseases through CD36, the main receptor of ox-LDL [17]. This evidence concerns the gene CD36 and eye disorder.